Literature DB >> 20128019

MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.

Cameron-M Smith, David I Watson, Michael Z Michael, Damian J Hussey.   

Abstract

Barrett's esophagus is a premalignant condition caused by gastroesophageal reflux. Once developed, it can progress through varying grades of dysplasia to esophageal adenocarcinoma. Whilst it is well accepted that Barrett's esophagus is caused by gastroesophageal reflux, the molecular mechanisms of its pathogenesis and progression to cancer remain unclear. MicroRNAs (miRNAs) are short segments of RNA that have been shown to control the expression of many human genes. They have been implicated in most cellular processes, and the role of miRNAs in disease development is becoming increasingly evident. Understanding altered miRNA expression is likely to help unravel the molecular mechanisms that underpin the development of Barrett's esophagus and its progression to cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128019      PMCID: PMC2816263          DOI: 10.3748/wjg.v16.i5.531

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  67 in total

1.  The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.

Authors:  Takatsugu Kan; Fumiaki Sato; Tetsuo Ito; Nobutoshi Matsumura; Stefan David; Yulan Cheng; Rachana Agarwal; Bogdan C Paun; Zhe Jin; Alexandru V Olaru; Florin M Selaru; James P Hamilton; Jian Yang; John M Abraham; Yuriko Mori; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

2.  MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.

Authors:  Ewy A Mathé; Giang Huong Nguyen; Elise D Bowman; Yiqiang Zhao; Anuradha Budhu; Aaron J Schetter; Rosemary Braun; Mark Reimers; Kensuke Kumamoto; Duncan Hughes; Nasser K Altorki; Alan G Casson; Chang-Gong Liu; Xin Wei Wang; Nozomu Yanaihara; Nobutoshi Hagiwara; Andrew J Dannenberg; Masao Miyashita; Carlo M Croce; Curtis C Harris
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

3.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

4.  MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Hushan Yang; Jian Gu; Kenneth K Wang; Wei Zhang; Jinliang Xing; Zhinan Chen; Jaffer A Ajani; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

5.  Decreased expression of microRNA-143 and -145 in human gastric cancers.

Authors:  Takeshi Takagi; Akio Iio; Yoshihito Nakagawa; Tomoki Naoe; Nobuhiko Tanigawa; Yukihiro Akao
Journal:  Oncology       Date:  2009-05-12       Impact factor: 2.935

6.  MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.

Authors:  Dipen M Maru; Rajesh R Singh; Christina Hannah; Constance T Albarracin; Yong X Li; Ronald Abraham; Angela M Romans; Hui Yao; Madan G Luthra; Sharmila Anandasabapathy; Stephen G Swisher; Wayne L Hofstetter; Asif Rashid; Rajyalakshmi Luthra
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

7.  miR-145 inhibits breast cancer cell growth through RTKN.

Authors:  Shihua Wang; Chunjing Bian; Zhuo Yang; Ye Bo; Jing Li; Lifen Zeng; Hong Zhou; Robert Chunhua Zhao
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

8.  Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Akio Iio; Tomoki Naoe
Journal:  Leuk Res       Date:  2009-05-21       Impact factor: 3.156

9.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

Authors:  Tao Li; Dong Li; Jianjun Sha; Peng Sun; Yiran Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

10.  miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments.

Authors:  Andreas Keller; Petra Leidinger; Anne Borries; Anke Wendschlag; Frank Wucherpfennig; Matthias Scheffler; Hanno Huwer; Hans-Peter Lenhof; Eckart Meese
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more
  21 in total

1.  Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.

Authors:  Ying Chang; Bin Liu; Gui-Sheng Liu; Tao Wang; Jun Gong
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.

Authors:  Cameron M Smith; David I Watson; Mary P Leong; George C Mayne; Michael Z Michael; Bas P L Wijnhoven; Damian J Hussey
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

Review 3.  Genetic factors in the pathogenesis of gastroesophageal reflux disease.

Authors:  Uday C Ghoshal; Dipti Chourasia
Journal:  Indian J Gastroenterol       Date:  2011-05-12

Review 4.  Molecular mechanisms of Barrett's esophagus.

Authors:  Hao Chen; Yu Fang; Whitney Tevebaugh; Roy C Orlando; Nicholas J Shaheen; Xiaoxin Chen
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

5.  Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.

Authors:  Yanying Wang; Qingxiu Wang; Na Zhang; Hong Ma; Yuchun Gu; Hongming Tang; Zengguang Xu; Yong Gao
Journal:  Tumour Biol       Date:  2014-08-19

Review 6.  miRNAs in precancerous lesions of the gastrointestinal tract.

Authors:  Matteo Fassan; Carlo M Croce; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

7.  MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.

Authors:  Thomas X Lu; Joseph D Sherrill; Ting Wen; Andrew J Plassard; John A Besse; Juan Pablo Abonia; James P Franciosi; Philip E Putnam; Michael Eby; Lisa J Martin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2012-03-03       Impact factor: 10.793

8.  Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.

Authors:  Rihong Zhai; Yongyue Wei; Li Su; Geoffrey Liu; Mathew H Kulke; John C Wain; David C Christiani
Journal:  Carcinogenesis       Date:  2014-11-08       Impact factor: 4.944

9.  MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.

Authors:  Mirte Mayke Streppel; Shweta Pai; Nathaniel R Campbell; Chaoxin Hu; Shinichi Yabuuchi; Marcia Irene Canto; Jean S Wang; Elizabeth A Montgomery; Anirban Maitra
Journal:  Clin Cancer Res       Date:  2013-06-11       Impact factor: 12.531

10.  miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.

Authors:  Qiang Fu; Jun Zhang; Xin Xu; Fei Qian; Ke Feng; Jie Ma
Journal:  Tumour Biol       Date:  2016-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.